BridgeBio Pharma BBIO Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's other intangible assets—net?
- BridgeBio Pharma (BBIO) reported other intangible assets—net of $27.36M in Q1 2026.
- How has BridgeBio Pharma's other intangible assets—net changed year-over-year?
- BridgeBio Pharma's other intangible assets—net decreased by 1.6% year-over-year, from $27.8M to $27.36M.